CXCL10



CXCL10

V1VV1P2PP2L3LL3S4SS4R5RR5T6TT6V7VV7R8RR8C9CC9T10TT10C11CC11I12II12S13SS13I14II14S15SS15N16NN16Q17QQ17P18PP18V19VV19N20NN20P21PP21R22RR22S23SS23L24LL24E25EE25K26KK26L27LL27E28EE28I29II29I30II30P31PP31A32AA32S33SS33Q34QQ34F35FF35C36CC36P37PP37R38RR38V39VV39E40EE40I41II41I42II42A43AA43T44TT44M45MM45K46KK46K47KK47... and 30 more residue(s)...... and 30 more residue(s)

SMILES None
InChIKey None
Sequence VPLSRTVRCTCISISNQPVNPRSLEKLEIIPASQFCPRVEIIATMKKKGEKRCLNPESKAIKNLLKAVSKERSKRSP

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections

Ligand site mutations CXCR3


No bioactivity data available.

CXCL10

V1VV1P2PP2L3LL3S4SS4R5RR5T6TT6V7VV7R8RR8C9CC9T10TT10C11CC11I12II12S13SS13I14II14S15SS15N16NN16Q17QQ17P18PP18V19VV19N20NN20P21PP21R22RR22S23SS23L24LL24E25EE25K26KK26L27LL27E28EE28I29II29I30II30P31PP31A32AA32S33SS33Q34QQ34F35FF35C36CC36P37PP37R38RR38V39VV39E40EE40I41II41I42II42A43AA43T44TT44M45MM45K46KK46K47KK47... and 30 more residue(s)...... and 30 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Ligand site mutations CXCR3


Compound is not listed as a drug.